substitution
Scarcity substitution notice issued
Pharmacists now able to substitute alternatives for menopause treatment after a scarcity notification was issued The Therapeutic Goods Administration (TGA) has advised of a shortage of all strengths of …
Scarcity drives pharmacy substitution
Community pharmacists are now able to substitute Actemra formulations without prior prescriber approval, due to serious shortages Two tocilizumab (Actemra) formulations are now effectively interchangeable at the pharmacy level after …
Keeping up with biosimilars
Pharmacy has a prominent role in the supply and provision of biosimilar medicines, and the profession has been slow to come to terms with this. Is the situation now changing? …
Concerns over substitution by pharmacists
Mixed views over medicine substitution by pharmacists as Parliament debates TGA amendment bill There have been divergences of opinions expressed in Federal Parliament about the substitution of medicines by pharmacists …
Livelihoods under threat
Thousands of pharmacy and other retail jobs at risk from Jobseeker cuts as businesses and employees are set to suffer financially, MPs tell Parliament Federal parliamentarians have debated the impact …
Script substitute
Government releases details on proposed pharmacist medicine substitution process, but concerns are raised that it’s “too complex, too slow” The Therapeutic Goods Administration (TGA) has released details on the Federal …
Call for 7CPA, lift on substitution rules
During the COVID-19 pandemic, the general public badly needs certainty around access to medicines, says one pharmacy leader Following the postponement of the Pharmacy Guild’s flagship Australian Pharmacy Professional Conference …
Unauthorised generic substitutions, changes warning
Some pharmacists feel that they can make generic substitutions or changes to instructions where this is unauthorised, thinking these actions have no consequence – but that’s not the case In …
Biologics switching is in pharmacists’ scope
Pharmacists’ authority to use their expertise to substitute one medicine for another should also apply to biological medicines, says FIP The International Pharmaceutical Federation has published a revised Statement of …
Consumers Health Forum worried on biosimilars
The Consumers Health Forum has expressed its concerns about the issue of substitution of biological medicines with biosimilars, at a meeting called by the Pharmaceutical Benefits Advisory Committee. CEO of …